Quantcast
404
Page not found.

The requested document is no more, No file found, Even tried multi, Nothing helped.

Try Searching
latest
ImmunoGen Beats Expectations: Gives Strong Guidance For Fiscal 2015

ImmunoGen has provided strong guidance for fiscal 2015, after announcing fourth-quarter earnings, beating estimates by 1.4 cents...

Arena Pharmaceuticals Posts Increased Revenue In Second Quarter

An increase in Belviq’s prescription count boosts second-quarter revenues of Arena Pharmaceuticals...

Austrian Law Student Sues FB Over Violation Of Privacy Laws

Austrian law student invites people around the globe to join class action privacy suit against Facebook over violation of EU privacy laws...

Synaptics Beats Estimates – Stock Gains 6%

Synaptics experienced 27% growth in revenues this year, and expects to continue growth of more than 20% in fiscal year 2015...

Citigroup Sells Off Another Non-Core Business

Citigroup has announced plans to sell 80% of its share in Metalmark Capital partners...

Scientific Games, Bally Technologies Surge On Merger

Scientific Games has agreed to acquire its rival Bally Technologies for $3.3 billion in an all-cash deal...

analysis
ImmunoGen Beats Expectations: Gives Strong Guidance For Fiscal 2015

After Burger King and Wal-Mart, it’s now Target’s turn to bring a change in its management with the appointment of Brain Cornell as the ...

Arena Pharmaceuticals Posts Increased Revenue In Second Quarter

While it is still going through a testing phase, Google Glass has already achieved the coveted status of becoming a must-have device for peo...

Austrian Law Student Sues FB Over Violation Of Privacy Laws

Clorox announced its fourth-quarter and full-year results for fiscal year 2014, missing the Street’s projections for both...

Synaptics Beats Estimates – Stock Gains 6%

The 26-year relationship, which was marked by Southwest Airlines painting killer whales on its planes, ends due to pressure from animal acti...

Citigroup Sells Off Another Non-Core Business

In a move to enhance transparency, Twitter has asked the Department of Justice (DOJ) for permission to reveal the data on government request...

Scientific Games, Bally Technologies Surge On Merger

The ongoing conflict between Israel and Palestine is one of the deadliest military operations in Gaza’s history. Israeli troops were able ...

more from bidness
Exxon Mobil (XOM) Bull Bear Case

In the bull case, Exxon’s stock price can increase to $129, assuming Brent Crude and Henry Hub natural gas prices increase. Higher US Gulf Coast cracking and marketing margins, and a P/E multiple will also boost the stock price. In the bear case, the P/E multiple of the company falls, as do crude oil and natural gas prices. Refining margins are hit and fall even lower than they are, causing Exxon’s stock price to plummet to $75. The price to earnings multiple used is the average price to earnings multiple in the time period in which Brent Crude prices had fallen considerably for the bear case and had significantly risen for the bull case.

American Express (AXP) Valuation Sheet

American Express operates in a highly competitive industry, with card companies often undercutting each other for higher market share. It has a one-year forward P/E multiple of 15.3x. The average P/E multiple of card service companies is 17.9x, while the XLF exchange-traded fund has a P/E multiple of 12.8x. American Express’s share price on November 11, 2013 was $81.2. The stock is trending in line with the market. The stock is also trading at a 15% premium to its five year historical average multiple and a 16% discount to its competitors’ average forward multiple

Visa (V) Valuation Sheet

Visa currently has a market cap of $120 billion, the highest amongst US card services companies. It has a 5yr revenue CAGR (compound annual growth rate) of 12.5%, and a one year forward P/E multiple of 21.9x. The average P/E multiple of card service companies is 17.9x, while the XLF exchange-traded fund has a P/E multiple of 12.8x. As of November 11, 2013, Visa’s share price is $199. Using analysts’ consensus estimates for EPS of $8.89 in FY14, its shares are currently trading at a 51% premium to the S&P 500 and a 75% premium to the XLF exchange-traded fund. The stock is also trading at a 22% premium to its five year historical average multiple and a 25% premium to its competitors’ average forward multiples.

Forgot Password

Enjoy all premium content at BidnessEtc for free now!

Enjoy all premium content at BidnessEtc for free now!